The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of rituximab on remissions without minimal residual disease and immunogenicity in patients with relapsed/refractory hairy cell leukemia receiving moxetumomab pasudotox.
 
Robert J. Kreitman
Research Funding - AstraZeneca; Genentech; Novartis; Pfizer; Teva
Patents, Royalties, Other Intellectual Property - NIH/NCI
 
Constance Yuan
No Relationships to Disclose
 
Hao-Wei Wang
No Relationships to Disclose
 
Hong Zhou
No Relationships to Disclose
 
Mark Raffeld
No Relationships to Disclose
 
Liqiang Xi
No Relationships to Disclose
 
Evgeny Arons
No Relationships to Disclose
 
Julie Feurtado
No Relationships to Disclose
 
Lacey James-Echenique
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
Raul Braylan
No Relationships to Disclose
 
Katherine R. Calvo
No Relationships to Disclose
 
Irina Maric
No Relationships to Disclose
 
Ira Pastan
Patents, Royalties, Other Intellectual Property - Evotec; NIH National Center for Advancing Translational Sciences (NCATS)